Cinctive Capital Management’s Vera Therapeutics VERA Stock Holding History

Cinctive Capital Management’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$532K	Sell	12,402 -93,682	-88%	-$3.49M	0.02%	356
2026 Q1	$4.27M	Buy	106,084 +41,467	+64%	+$1.79M	0.28%	128
2025 Q4	$3.27M	Sell	64,617 -31,956	-33%	-$1.14M	0.18%	156
2025 Q3	$2.81M	Sell	96,573 -65,510	-40%	-$1.51M	0.13%	216
2025 Q2	$3.82M	Buy	162,083 +135,719	+515%	+$3.05M	0.2%	153
2025 Q1	$633K	Sell	26,364 -87,182	-77%	-$2.8M	0.05%	244
2024 Q4	$4.8M	Buy	113,546 +65,046	+134%	+$2.88M	0.24%	136
2024 Q3	$2.14M	Buy	48,500 +13,728	+39%	+$521K	0.12%	227
2024 Q2	$1.26M	Buy	+34,772	New	+$1.38M	0.06%	283

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cinctive Capital Management's VERA Position: Q2 2026 in Review

Cinctive Capital Management reduced its Vera Therapeutics (VERA) stake by 88% in Q2 2026, selling an estimated $3.49M and leaving 12,402 shares worth $532K. The position accounts for 0.02% of the portfolio, ranked #356.

Cinctive Capital Management first reported a position in VERA in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.8M in Q4 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Cinctive Capital Management held 12,402 shares of Vera Therapeutics worth $532K as of Q2 2026.
Cinctive Capital Management sold 93,682 Vera Therapeutics shares in Q2 2026, an estimated $3.49M.
Vera Therapeutics made up 0.02% of Cinctive Capital Management's portfolio in Q2 2026, its #356 holding.
Cinctive Capital Management first reported a position in Vera Therapeutics in Q2 2024 and has held it in 9 quarters since.
Cinctive Capital Management's Vera Therapeutics position peaked at $4.8M in Q4 2024.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.